Evidence map›Paper›PMID 41264163›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Global trends in artificial intelligence applications for gastric cancer prediction, treatment, and management: a topic modeling and bibliometric analysis.

Vu Anh Trong Dam, Jeongseon Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vu Anh Trong DamDepartment of Public Health & AI, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea.
Jeongseon KimDepartment of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea. jskim@ncc.re.kr.ORCID http://orcid.org/0000-0002-0889-2686

Funding

International Cooperation & Education Program of National Cancer Center, Korea 2025International Cooperation & Education Program of National Cancer Center, Korea NCCRI·NCCI 52210-52211National Cancer Center Intramural Grant, Korea 2510880
6 · The paper itself

Abstract

purposeArtificial intelligence (AI) emerged as a promising tool for enhancing healthcare delivery and outcomes for gastric cancer (GC) patients. This study aimed to analyze research development, patterns, and trends in AI applications on GC.

methodsIn total, 1,854 publications from the Web of Science database (1993-2024) were extracted. Text-mining and bibliometric tools were employed to examine co-occurrence networks, global collaborations, and frequently used terms. Latent Dirichlet Allocation and dendrogram analysis identified hidden topics and clustered key research domains, while linear regression models evaluated research trends.

resultsThis study highlighted a growing interest in AI applications for GC, with China, Japan, and the United States as leading contributors. However, an unequal distribution of research interest is disadvantaging low- and middle-income countries (LMICs) despite their higher cancer burden. Topic modeling revealed that Comparative Analysis of Robotic vs. Laparoscopic Gastrectomy Topic is the most studied area, though its interest has declined over the past five years. Emerging areas include AI applications in Tumor Segmentation, Predictive Models, Dietary and Environmental GC Prevention, Cell-Free DNA and Biomarkers. This study emphasized the AI's interdisciplinary nature, along with integrating computer science with clinical fields to advance GC diagnosis and treatment.

conclusionThe findings suggested that policymakers should prioritize targeted funding and equitable AI adoption in LMICs to reduce disparities. Furthermore, strategic efforts should be directed toward improving the quality of life for GC patients. Future studies should focus on addressing AI algorithm's limitations and building effective AI tools to improve treatment outcomes for population-specific demands.

Indexed as

Artificial IntelligenceBibliometricsStomach NeoplasmsHumansArtificial intelligenceBibliometric analysisGastric cancerTopic modelingTrend

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.